PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 16, 20260 citationsOpen Access

A TCRbeta1/ TCRbeta2 (TRBC1/ TRBC2) antibody pair for determining T-cell monotypia as a surrogate for clonality in formalin fixed paraffin embedded material

View Full Paper
ESElizabeth J. SoilleuxAKAnuradha KaisthaSEShelley Evans

Key Points

  • The aim is to evaluate the use of TCRβ1 and TCRβ2 monoclonal antibodies for diagnosing T-cell lymphomas through immunohistochemical analysis.
  • Developed monoclonal antibodies against TCRβ1 and TCRβ2
  • Conducted immunohistochemical detection in formalin-fixed paraffin-embedded tissues
  • Tested samples from 13 T-cell lymphomas and 8 benign T-cell populations
  • Performed automated cell counting for TCRβ2:TCRβ1 ratio calculation
  • Demonstrated effective detection of TCRβ1 and TCRβ2 in T-cell lymphomas
  • Shown feasibility of single immunostaining as a diagnostic tool
  • Presented data supporting accurate calculation of TCRβ2:TCRβ1 ratios
  • Indicated potential for quicker and less expensive diagnostics compared to traditional methods

Abstract

T-cell lymphomas are often histologically indistinguishable from benign T-cell infiltrates. Clonality testing is frequently required for diagnosis. It lacks the spatial context and is slow and expensive, relying on complex, multiplexed PCR reactions, interpreted by scientists or pathologists with specialist molecular training. We have developed a pair of highly specific monoclonal antibodies against the two alternatively used, but very similar, T-cell receptor β constant regions, TCRβ1 and TCRβ2 (encoded by the TRBC1 and TRBC2 gene segments). We demonstrate the feasibility of immunohistochemical detection of TCRβ1 and TCRβ2 in formalin-fixed, paraffin-embedded (FFPE) tissue as a novel diagnostic strategy for T-cell lymphomas. Single immunostaining results are presented for 13 T-cell lymphomas and 8 benign T-cell populations, together with illustrative examples of TCRβ1/2 double immunostaining. Finally, we show that this single immunostaining is amenable to automated cell counting, permitting accurate calculation of the TCRβ2:TCRβ1 ratio. This novel assay can be used in a similar way to the kappa/ lambda assay for B-cell and plasma cell neoplasms.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Soilleux et al. (2026) studied this question.

synapsesocial.com/papers/69e07dc72f7e8953b7cbec94https://doi.org/10.17863/cam.129296
Ask AI
Helpful
Bookmark
Share
View Full Paper